We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Innovative Collimator Improves Breast Screening with Less Radiation

By MedImaging International staff writers
Posted on 28 Jun 2016
Print article
Image: The VASH collimator (Photo courtesy of JLab).
Image: The VASH collimator (Photo courtesy of JLab).
Adding a variable angle slant hole (VASH) collimator to an existing breast molecular imaging system provides better contrast of cancer lesions while potentially reducing radiation doses by half, according to a new study.

Developed by researchers at the Thomas Jefferson National Accelerator Facility (JLab; Newport, VA, USA), Dilon Technologies (Newport, VA, USA) and the University of Florida (UF, Gainesville, USA), the new VASH collimator is constructed from a stack of 49 tungsten sheets, each one a quarter of a millimeter thick containing an identical array of square holes. The sheets are stacked like a deck of cards, with angled edges on two sides; the angle of the array in the stack can be slanted by two small motors that slide the individual sheets. The result is a systematic varying of the focusing angle of the collimator during the imaging procedure.

In a study to test the system, the researchers evaluated the spatial resolution and contrast-to-noise ratio in breast phantom of a breast, with four beads inside that simulated cancer tumors of varying diameter and marked with a radiotracer. They found that when using the VASH collimator with an existing breast molecular imaging system, they got an image with six times better contrast, which could potentially reduce the radiation dose by half, while maintaining the same or better image quality. The test results were presented at the Society of Nuclear Medicine and Molecular Imaging annual meeting, held during June 2016 in San Diego (CA, USA).

“While a mammogram uses X-rays to show the structure of breast tissue, molecular breast imagers show tissue function. A radiotracer attached to the molecule gives off gamma rays, which can be picked up by the molecular breast imager,” said Drew Weisenberger, PhD, leader of the JLab radiation detector and imaging group. “Now, you can get a whole range of angles of projections of the breast without moving the breast or moving the imager. You're able to come in real close, you're able to compress the breast, and you can get a one-to-one comparison to a 3D mammogram.”

Mammography is the gold standard of breast cancer screening; but about half of all women who follow standard screening protocol for 10 years will receive a false-positive result that will require additional screening. Used in conjunction with mammography, imaging based on nuclear medicine is a successful secondary screening technique to reduce the number of false positive results in women with dense breasts and at higher risk for developing breast cancer.

Related Links:
Thomas Jefferson National Accelerator Facility
Dilon Technologies
University of Florida
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Advanced Cardiac MRI Analysis Software
3Di Cardiac MR
New
Ultrasound Doppler System
Doppler BT-200
Imaging Table
Stille imagiQ2

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.